ClinicalTrials.Veeva

Menu

Evaluation of Early Retinal Nerve Injury in Type 2 Diabetes Patients Without Diabetic Retinopathy

Sun Yat-sen University logo

Sun Yat-sen University

Status

Unknown

Conditions

Diabetes Mellitus
Nerve Injury
Diabetic Retinopathy

Treatments

Device: routine ophthalmic examination

Study type

Interventional

Funder types

Other

Identifiers

NCT03970161
Retinal nerve injury in T2DM

Details and patient eligibility

About

The object of this study is to investigate the damage to the retinal nerve fiber layer (RNFL) and ganglion cell complex layer (GCL+) in diabetic patients without retinal microangioma as detected by fundus fluorescein angiography (FFA) and to determine the kind of nerve damage more likely to indicate early injury.

Full description

Patients with type 2 diabetes mellitus and healthy volunteers will be included in our study. Patients with retinal microangioma are excluded by FFA. The parameters around the optic disc and macular area of the above two groups are measured by optical coherence tomography (OCT), and the results will be analyzed using the SPSS 22.0 software.

Enrollment

720 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients with T2DM
  2. Patients without microangioma

Exclusion criteria

  1. Patients with any other ocular disease that might affect retinal nerve injury
  2. Patients with optic neuropathy, age-related macular degeneration, retinal and choroidal disease, and retinal artery/vein occlusion.
  3. Patients with hypertension, hematopathy, neuropathy, and other systemic diseases causing retinal nerve changes.
  4. Patients with keratopathy, cataract, and vitreous hemorrhage were also excluded.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

720 participants in 2 patient groups

T2DM Patients
Experimental group
Description:
Patients without microangioma changes undergoing FFA examination were included in the present study. All of the participants enrolled in the present study underwent a systematic ophthalmic examination.
Treatment:
Device: routine ophthalmic examination
healthy control subjects
Experimental group
Description:
All of the participants enrolled in the present study underwent a systematic ophthalmic examination.
Treatment:
Device: routine ophthalmic examination

Trial contacts and locations

1

Loading...

Central trial contact

Xiang Zhu

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems